Selected Financial Data
since 2005
Income Statement
Allergan PLC, selected items from income statement, long-term trends
US$ in thousands
| 12 months ended: | Net revenues | Operating income (loss) | Net income (loss) attributable to shareholders |
|---|---|---|---|
| Dec 31, 2019 | 16,088,900) | (4,445,300) | (5,271,000) |
| Dec 31, 2018 | 15,787,400) | (6,247,600) | (5,096,400) |
| Dec 31, 2017 | 15,940,700) | (5,921,200) | (4,125,500) |
| Dec 31, 2016 | 14,570,600) | (1,825,500) | 14,973,400) |
| Dec 31, 2015 | 15,071,000) | (3,014,500) | 3,915,200) |
| Dec 31, 2014 | 13,062,300) | (1,267,700) | (1,630,500) |
| Dec 31, 2013 | 8,677,600) | (423,200) | (750,400) |
| Dec 31, 2012 | 5,914,900) | 320,800) | 97,300) |
| Dec 31, 2011 | 4,584,400) | 536,200) | 260,900) |
| Dec 31, 2010 | 3,566,900) | 305,400) | 184,400) |
| Dec 31, 2009 | 2,793,000) | 383,900) | 222,000) |
| Dec 31, 2008 | 2,535,501) | 358,128) | 238,379) |
| Dec 31, 2007 | 2,496,651) | 255,660) | 141,030) |
| Dec 31, 2006 | 1,979,244) | (422,096) | (445,005) |
| Dec 31, 2005 | 1,646,203) | 218,512) | 138,233) |
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Assets
Allergan PLC, selected items from assets, long-term trends
US$ in thousands
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2019 | 11,126,700) | 94,699,100) |
| Dec 31, 2018 | 6,475,400) | 101,787,600) |
| Dec 31, 2017 | 11,376,700) | 118,341,900) |
| Dec 31, 2016 | 17,857,900) | 128,986,300) |
| Dec 31, 2015 | 8,615,400) | 135,840,700) |
| Dec 31, 2014 | 6,881,700) | 52,529,100) |
| Dec 31, 2013 | 4,434,700) | 22,725,900) |
| Dec 31, 2012 | 3,879,700) | 14,103,500) |
| Dec 31, 2011 | 2,569,700) | 6,698,300) |
| Dec 31, 2010 | 1,799,400) | 5,827,300) |
| Dec 31, 2009 | 1,771,000) | 5,992,200) |
| Dec 31, 2008 | 1,458,417) | 3,677,887) |
| Dec 31, 2007 | 1,173,776) | 3,472,027) |
| Dec 31, 2006 | 1,261,676) | 3,760,577) |
| Dec 31, 2005 | 1,360,430) | 3,080,033) |
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Liabilities and Stockholders’ Equity
Allergan PLC, selected items from liabilities and stockholders’ equity, long-term trends
US$ in thousands
| Current liabilities | Total liabilities | Total debt and capital leases | Shareholders’ equity | |
|---|---|---|---|---|
| Dec 31, 2019 | 11,070,700) | 36,502,700) | 22,649,000) | 58,173,600) |
| Dec 31, 2018 | 5,727,900) | 36,656,600) | 23,797,700) | 65,114,100) |
| Dec 31, 2017 | 9,848,100) | 44,504,800) | 30,075,300) | 73,821,100) |
| Dec 31, 2016 | 7,874,700) | 52,785,800) | 32,768,700) | 76,192,700) |
| Dec 31, 2015 | 8,328,300) | 59,251,400) | 42,726,200) | 76,591,400) |
| Dec 31, 2014 | 5,018,600) | 24,193,600) | 15,543,700) | 28,331,100) |
| Dec 31, 2013 | 3,294,900) | 13,188,800) | 9,052,000) | 9,532,100) |
| Dec 31, 2012 | 2,710,600) | 10,247,100) | 6,433,300) | 3,833,800) |
| Dec 31, 2011 | 1,839,500) | 3,135,800) | 1,033,000) | 3,563,600) |
| Dec 31, 2010 | 820,700) | 2,544,700) | 1,016,100) | 3,281,700) |
| Dec 31, 2009 | 1,052,400) | 2,969,100) | 1,457,800) | 3,023,100) |
| Dec 31, 2008 | 481,995) | 1,569,302) | 877,893) | 2,108,585) |
| Dec 31, 2007 | 444,927) | 1,622,562) | 905,649) | 1,849,465) |
| Dec 31, 2006 | 689,929) | 2,080,189) | 1,231,204) | 1,680,388) |
| Dec 31, 2005 | 245,670) | 975,792) | 587,935) | 2,104,241) |
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Cash Flow Statement
Allergan PLC, selected items from cash flow statement, long-term trends
US$ in thousands
| 12 months ended: | Net cash provided by operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
|---|---|---|---|
| Dec 31, 2019 | 7,238,700) | (2,858,800) | (2,766,100) |
| Dec 31, 2018 | 5,640,100) | 3,098,500) | (9,680,100) |
| Dec 31, 2017 | 5,873,400) | (878,000) | (4,923,600) |
| Dec 31, 2016 | 1,425,300) | 24,333,300) | (25,122,100) |
| Dec 31, 2015 | 4,530,000) | (37,120,900) | 33,443,400) |
| Dec 31, 2014 | 2,243,000) | (5,370,600) | 3,017,500) |
| Dec 31, 2013 | 1,213,500) | (275,300) | (867,300) |
| Dec 31, 2012 | 665,800) | (5,749,000) | 5,189,600) |
| Dec 31, 2011 | 632,000) | (719,000) | 16,400) |
| Dec 31, 2010 | 571,000) | (74,100) | (411,300) |
| Dec 31, 2009 | 376,800) | (1,036,100) | 353,100) |
| Dec 31, 2008 | 416,554) | (93,357) | (20,173) |
| Dec 31, 2007 | 427,178) | (64,292) | (312,503) |
| Dec 31, 2006 | 471,365) | (1,419,419) | 634,774) |
| Dec 31, 2005 | 325,503) | 116,355) | (273,060) |
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Per Share Data
Allergan PLC, selected data per share, long-term trends
US$
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Dec 31, 2019 | -16.02 | -16.02 | 2.96 |
| Dec 31, 2018 | -15.26 | -15.26 | 2.88 |
| Dec 31, 2017 | -13.19 | -13.19 | 2.80 |
| Dec 31, 2016 | 38.18 | 38.18 | 0.00 |
| Dec 31, 2015 | 10.01 | 10.01 | 0.00 |
| Dec 31, 2014 | -7.42 | -7.42 | 0.00 |
| Dec 31, 2013 | -5.27 | -5.27 | 0.00 |
| Dec 31, 2012 | 0.77 | 0.76 | 0.00 |
| Dec 31, 2011 | 2.10 | 2.06 | 0.00 |
| Dec 31, 2010 | 1.51 | 1.48 | 0.00 |
| Dec 31, 2009 | 2.11 | 1.96 | 0.00 |
| Dec 31, 2008 | 2.32 | 2.09 | 0.00 |
| Dec 31, 2007 | 1.38 | 1.27 | 0.00 |
| Dec 31, 2006 | -4.37 | -4.37 | 0.00 |
| Dec 31, 2005 | 1.32 | 1.21 | 0.00 |
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.